These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1242089)
21. [Hyperglycemic hyperosmolar non-ketotic diabetic coma with prolonged insulin-resistnace and extremely high values of insulin-IgG-binding]. Gamba S; Bruni Bocher K; Hamid S; Bruni B Minerva Med; 1975 Oct; 66(72):3785-9. PubMed ID: 1187029 [TBL] [Abstract][Full Text] [Related]
22. Behaviour of insulin antibodies in diabetics treated with different insulins. Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044 [TBL] [Abstract][Full Text] [Related]
23. Investigation of anti-insulin antibodies by the radiochemical ethanol precipitation method. Fratino P; Gastaldi F Boll Soc Ital Biol Sper; 1976 Jul; 52(13):1004-8. PubMed ID: 1088079 [No Abstract] [Full Text] [Related]
24. [Role of dysgammaglobulinemia in evaluation of severity of diabetes and sensitivity to insulin in children with diabetes mellitus]. Dreval' AV; Zhukovskiĭ MA; Mikhaĭlova VS; Shcherbacheva LN; Malkina LA Sov Med; 1976 Jun; (6):36-40. PubMed ID: 1019722 [No Abstract] [Full Text] [Related]
25. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications. Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720 [No Abstract] [Full Text] [Related]
26. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment]. Bruni B; Turco GL Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430 [No Abstract] [Full Text] [Related]
27. Research on a new type of antiinsulin antibody in a diabetic female patient: the cytotoxic antibody. antiinsulin cytotoxic antibody. Mathov E; Greiding L Allergol Immunopathol (Madr); 1976; 4(1):1-14. PubMed ID: 1266688 [TBL] [Abstract][Full Text] [Related]
29. [Purity and antigenicity of the new insulin preparations]. Fankhauser S Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531 [TBL] [Abstract][Full Text] [Related]
30. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners]. Fabian W; Majkowska L; Stefański A; Moleda P Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234 [TBL] [Abstract][Full Text] [Related]
31. [Preliminary note on anti-insulin antibody formation in diabetics treated with porcine insulin]. Bchir F; Boujaafar N; Ben Salem M; Achour A Arch Inst Pasteur Tunis; 1984 Mar; 61(1):1-8. PubMed ID: 6398991 [TBL] [Abstract][Full Text] [Related]
32. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment. Bruni B; Gamba S; Regis G; Turco GL Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232 [TBL] [Abstract][Full Text] [Related]
33. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type]. Andreani D; Iavicoli M; Colletti A; Menzinger G Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824 [No Abstract] [Full Text] [Related]
34. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific]. Weber HU; Sourisseau D; Zahnd GR Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557 [No Abstract] [Full Text] [Related]
35. Insulin-specific IgE in serum of 67 diabetic patients against human insulin (Novo), porcine insulin, and bovine insulin. Four case reports. Falholt K; Hoskam JA; Karamanos BG; Süsstrunk H; Viswanathan M; Heding LG Diabetes Care; 1983; 6 Suppl 1():61-5. PubMed ID: 6343042 [TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to the insulin receptor: clinical and molecular aspects. Kahn CR Fed Proc; 1979 Nov; 38(12):2607-9. PubMed ID: 499577 [No Abstract] [Full Text] [Related]
37. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin. Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730 [No Abstract] [Full Text] [Related]
38. [The antigenicity of various new chromatographically purified depot insulin preparations]. Graber D; Fankhauser S Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418 [TBL] [Abstract][Full Text] [Related]
39. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
40. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]